EPO Aggressive Dosing May Be Curtailed By New Black Box Warning
This article was originally published in The Pink Sheet Daily
Executive Summary
Labeling for Amgen’s Aranesp and Epogen and Johnson & Johnson’s Procrit updated March 9 to include a black box warning on risk of mortality.
You may also be interested in...
Amgen Says 2007 Profits Will Top October Projections
California biotech cites cost-cutting measures as reason for upgraded earnings per share guidance of $4.30.
Amgen Says 2007 Profits Will Top October Projections
California biotech cites cost-cutting measures as reason for upgraded earnings per share guidance of $4.30.
Amgen, J&J Revise Labels For Aranesp, Epogen, Procrit
Amgen says it will present new data to CMS in effort to persuade agency to modify its National Coverage Decision on ESAs.